secwatch.observer — SEC 8-K summary
======================================

Issuer:     SAB Biotherapeutics, Inc. (SABS)
CIK:        0001833214
Form:       8-K
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0001437749-23-007867
Event type: litigation
Sentiment:  negative
Materiality: 0.65
Item codes: 2.03, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

SAB Biotherapeutics settles Ladenburg lawsuit; issues warrant and agrees to pay $3.1M
--------------------------------------------------------------------------------

- Issued warrant for 300,000 shares at $0.5424 per share and paid $500K cash upfront.
- Must pay $1.5M by June 30, 2023, and $1.1M by Dec 31, 2023, in cash or stock at Company's option.
- Ladenburg Action will be dismissed with prejudice after obligations completed.
- Warrant issued under Section 4(a)(2) and Rule 506 of Regulation D as unregistered sale.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1833214/000143774923007867/0001437749-23-007867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1833214/000143774923007867/sabs20230324_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-007867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer